A pragmatic randomised controlled trial in primary care of the Camden Weight Loss (CAMWEL) programme

London School of Hygiene & Tropical Medicine, London, UK.
BMJ Open (Impact Factor: 2.27). 05/2012; 2(3). DOI: 10.1136/bmjopen-2011-000793
Source: PubMed


To evaluate effectiveness of a structured one-to-one behaviour change programme on weight loss in obese and overweight individuals.
Randomised controlled trial.
23 general practices in Camden, London.
381 adults with body mass index ≥25 kg/m(2) randomly assigned to intervention (n=191) or control (n=190) group.
A structured one-to-one programme, delivered over 14 visits during 12 months by trained advisors in three primary care centres compared with usual care in general practice.
Changes in weight, per cent body fat, waist circumference, blood pressure and heart rate between baseline and 12 months.
217/381 (57.0%) participants were assessed at 12 months: missing values were imputed. The difference in mean weight change between the intervention and control groups was not statistically significant (0.70 kg (0.67 to 2.17, p=0.35)), although a higher proportion of the intervention group (32.7%) than the control group (20.4%) lost 5% or more of their baseline weight (OR: 1.80 (1.02 to 3.18, p=0.04)). The intervention group achieved a lower mean heart rate (mean difference 3.68 beats per minute (0.31 to 7.04, p=0.03)) than the control group. Participants in the intervention group reported higher satisfaction and more positive experiences of their care compared with the control group.
Although there is no significant difference in mean weight loss between the intervention and control groups, trained non-specialist advisors can deliver a structured programme and achieve clinically beneficial weight loss in some patients in primary care. The intervention group also reported a higher level of satisfaction with the support received. Primary care interventions are unlikely to be sufficient to tackle the obesity epidemic and effective population-wide measures are also necessary.
Trial registrationClincaltrials.gov NCT00891943.

Download full-text


Available from: Kiran Nanchahal,
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background and aims The beneficial effect of cognitive therapy was found particularly in eating disorders, but, to date, it has rarely been studied in obese patients without eating disorders. The aim of this pragmatic randomized clinical trial was to evaluate the effectiveness of a novel brief group cognitive behavioural treatment (CBT), accepted and performed in clinical practice, in addition to a prescriptive diet with respect to the prescriptive diet alone (standard care), in obese and overweight outpatients without eating disorders. Methods One hundred sixty three patients [44 men and 119 women; 45±11 yr; mean body mass index (BMI) of 32±4 kg/m2] aged 18-65 years who were from overweight (BMI between 25-29.9) to 2° class obese (BMI between 35-39.9 kg/m2) were followed for 12 months in a public obesity ambulatory. The study was based on a nutritional intervention lasting for six months. Weight loss was obtained with a hypo caloric balanced diet. Standard care consisted in a low-calorie diet, and a control visit every three months. Group CBT patients received the same diet but in addition they attended a series of seven subsequent meetings divided in small groups. Primary outcome is defined as the percentage of patients in each group achieving a 10% reduction of body weight at 12 months in comparison with baseline value. After randomization, at baseline patients underwent laboratory tests, bioelectrical impedance analysis, ECG and psychometric tests, and they were followed-up at six and 12 months. Results The average weight loss obtained at six and 12 months was respectively 6.0% and 7.44% for all patients, and this is in accordance with other similar studies. The primary outcome has been reached by 19 patients (24%) out of 78 who concluded the follow-up. Considering an ITT univariate analysis, the primary outcome was independent from treatment arm (OR 0.854, CI 0.39-1.871, p=0.633) and the two treatments were substantially similar. Metabolic parameters (glucose levels, lipid profile, blood pressure), as expected, ameliorated in both groups during follow-up. The only independent predictor of successful weight loss was baseline glucose levels (OR 1.05, CI 1.009-1.09, p=0.04), thus representing a higher risk of disease perceived by patients. Conclusion A brief group CBT, when added to standard care, was not superior to standard care alone in obese patients. The peculiar course of CBT planned only in the first six months, as well as the absence of a pure cognitive analysis may have impacted on the CBT success lower than expected. Further studies are needed in order to determine if longer intervention may be effective and feasible in a real-life primary care setting.
    e-SPEN Journal 01/2013; 9(1). DOI:10.1016/j.clnme.2013.11.002
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Overweight and obesity are common and important causes of chronic disease. This should mean that primary care physicians feel tackling obesity is important, but it is uncommon for them to do so. Physicians perceive that this is not their job; they fear offending their patients and are unclear what may be effective. In this review we found two systematic reviews showing that motivational interviewing can lead to effective weight loss but it may not be practicable in this setting. Two trials show referral to specially trained nurses in primary care appears ineffective. Several randomized trials show referral to commercial weight management companies is effective. Observational data but no trials suggest that screening for and opportunistic brief interventions may motivate attempts to lose weight and lead to some weight loss. We conclude there is insufficient evidence to promote treatment opportunistically but sufficient evidence to refer patients wanting to lose weight to commercial weight management services.
    12/2013; 2(4). DOI:10.1007/s13679-013-0073-8
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Government and societal efforts to combat obesity are aimed at prevention, although there is a generation for whom excess weight is the rule rather than the exception. Although measures to prevent a worsening of the current epidemic are important, management of obesity must also be prioritised. Obesity management is beset with problems ranging from attitudinal to clinical and pharmacological, and the individualisation of therapy.
    BMC Medicine 08/2014; 12(1):149. DOI:10.1186/1741-7015-12-149 · 7.25 Impact Factor
Show more